Science

NASA Confirms Artemis Moon Landing Mission for 2026 With All-Female Crew

NASA confirmed the Artemis III mission is on track for a 2026 lunar landing, with a crew of four including the first two women ever to set foot on the Moon's surface.

P
Priya Sharma
May 12, 20261 min read 28 views
Share:

Back to the Moon

NASA confirmed that Artemis III, the first crewed lunar landing since Apollo 17 in 1972, is on schedule for late 2026. The four-person crew includes Mission Specialists Christina Koch and Zena Cardman, who will become the first women to walk on the lunar surface, alongside Commander Reid Wiseman and Pilot Victor Glover.

Landing Zone: The Lunar South Pole

Unlike Apollo, which landed in equatorial regions, Artemis III will touch down near the lunar south pole — a region permanently shadowed in some craters where ice water has been confirmed by orbital observations. This water is critical for future sustained human presence and as a source of rocket propellant.

"We are going back to the Moon not to plant a flag and leave. We are going to stay — and Artemis III is how it begins," said NASA's administrator at a press conference at Kennedy Space Centre.

Key Technology

The mission uses SpaceX's Starship Human Landing System, a fully reusable lunar lander capable of returning astronauts to the orbiting Gateway station. Artemis III will spend approximately 6.5 days on the surface — three times longer than the longest Apollo mission.

Related Stories

James Webb Telescope Discovers Oldest Galaxy Ever Observed, Just 300 Million Years After Big BangScience

James Webb Telescope Discovers Oldest Galaxy Ever Observed, Just 300 Million Years After Big Bang

Astronomers using the James Webb Space Telescope announced the discovery of JADES-GS-z14-0, a galaxy that existed just 290 million years after the Big Bang, shattering the previous record.

Priya Sharma Apr 28, 2026
3 min read
CRISPR Gene Therapy Achieves First Complete Cure of Sickle Cell Disease in Clinical TrialScience

CRISPR Gene Therapy Achieves First Complete Cure of Sickle Cell Disease in Clinical Trial

Researchers reported that 42 out of 42 patients in a phase 3 clinical trial of a CRISPR-based gene therapy are free of sickle cell disease crises, with the longest follow-up now at five years.

Apr 22, 2026
3 min read

Comments (0)

Leave a Comment

Sign in or create an account to comment with your name saved.